Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | SI | P14410 | 1/20 | 0.50 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 4/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | POLA1 | P09884 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.32 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.31 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13191188 | 0.82 | TSHR (0.56) | MGAMGAASIMGAM2TSHR | |
| SCHEMBL14314040 | 0.81 | MGAM (0.50) | MGAMGAASIMGAM2TSHR | |
| SCHEMBL26657832 | 0.81 | MGAM (0.50) | MGAMGAASIMGAM2TSHR | |
| SCHEMBL9448983 | 0.81 | MGAM (0.50) | MGAMGAASIMGAM2TSHR | |
| SCHEMBL9448987 | 0.81 | MGAM (0.50) | MGAMGAASIMGAM2TSHR | |
| SCHEMBL6965002 | 0.79 | — | — | |
| SCHEMBL17767250 | 0.75 | — | — | |
| SCHEMBL17767249 | 0.75 | — | — | |
| SCHEMBL17775762 | 0.75 | — | — | |
| SCHEMBL14536747 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013076148-A2 | PERSONAL CARE COMPOSITIONS WITH ENHANCED FRAGRANCE DELIVERY VIA POLYHYDROXY QUATERNARY AMMONIUM SALTS | UNILEVER PLC (GB) | 2013-05-30 | — | — | WO | claimed |
| EP-2148649-B1 | PERSONAL CARE COMPOSITIONS WITH ENHANCED FRAGRANCE DELIVERY | UNILEVER PLC NO 41424 (GB) | 2011-02-09 | — | — | EP | claimed |
| EP-2148649-A1 | PERSONAL CARE COMPOSITIONS WITH ENHANCED FRAGRANCE DELIVERY | Unilever Plc, A Company Registered In England And Wales under company no. 41424 of Unilever House (GB) | 2010-02-03 | — | — | EP | claimed |
| US-20080299054-A1 | PERSONAL CARE COMPOSITIONS WITH ENHANCED FRAGRANCE DELIVERY | CONOPCO, INC., D/B/A UNILEVER (US) | 2008-12-04 | — | — | US | claimed |
| WO-2008145582-A1 | PERSONAL CARE COMPOSITIONS WITH ENHANCED FRAGRANCE DELIVERY | UNILEVER PLC (GB) | 2008-12-04 | — | — | WO | claimed |
| US-6844302-B1 | Encapsulated flavor and fragrance | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2005-01-18 | — | — | US | claimed |
| US-20080299054-A1 | PERSONAL CARE COMPOSITIONS WITH ENHANCED FRAGRANCE DELIVERY | CONOPCO, INC., D/B/A UNILEVER (US) | 2008-12-04 | — | — | US | disclosed |
| US-6844302-B1 | Encapsulated flavor and fragrance | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2005-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080299054-A1 | PERSONAL CARE COMPOSITIONS WITH ENHANCED FRAGRANCE DELIVERY | CUTA, KAT5, PUF60 | MGAM 4383/4885GAA 2972/4885SI 3084/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.